Senior Director Medical Communications & Publications
Listed on 2026-09-13
-
Healthcare
Healthcare Management -
Management
Healthcare Management
At Verastem Oncology, we address urgent needs of patients living with cancers driven by RAS/MAPK pathway mutations, a key driver of tumor growth and treatment resistance. FDA approval of AVMAPKI FAKZYNJA CO-PACK delivered the first therapy for women living with recurrent KRAS-mutated low-grade serous ovarian cancer, a rare cancer with significant unmet need. We've launched this novel/novel combination therapy in the U.S. and are exploring pathways for Europe and Japan.
We continue to advance our pipeline of drugs to help block cancer cell survival, inhibit tumor growth, and overcome treatment resistance. This is an exciting opportunity to shape the future of cancer care and make a meaningful impact in the lives of patients.
The Senior Director, Medical Communications, will report to the Head of Medical Affairs. The individual will be accountable for Verastem's external communications for both avutometinib + defactinib and pipeline assets (VS7375), managing two direct reports who will themselves be responsible for the strategy, development, and review of scientific communications and publications, scientific platforms, congress publication plans, and other activities The position will partner cross functionally to ensure that all communications are scientifically/medically accurate and aligned
The individual will also have broad responsibilities in accountability for Medical information Call Center and internal review teams (PMR/MMR), management of external authors and partners for Scientific Communications, , coordination with cross-functional team members in development of evidence generation strategy, as well as leadership on the Medical Affairs Leadership Team (MALT).
- Accountable for overarching Medical Communications strategy, execution, and budget
- Management of two direct reports who are each responsible for asset-specific activities, one for avutometinib + defactinib, and one for VS7375
- Developing a broad and deep understanding of the strategic objectives for each asset, and representing the function in high-level strategic discussions (e.g., MALT, cross-functional teams, etc.)
- Assessing, modifying, and addressing the foundational elements of industry best-practices in Medical Communications, overseeing new policies, processes, or workflows as needed in a lean, fast-moving environment.
- Contribute to development of the overarching Medical Affairs strategy and provide leadership and guidance to internal partners during development of strategic plans and assets
- Broad oversight of Scientific/Medical Communications and Medical Information partners, ensuring that they meet expectations with respect to strategic input, deliverables, and budget
- Advocate for a strong scientific communication strategy through building effective relationships with key stakeholders across the organization and externally
- Provide visible leadership support to key alliance partners and joint venture partners, ensuring the right scientific and technical skills and capabilities from Publications / Scientific Communications and driving effective behaviors to support the success of strategic alliances.
- Execute best practices within oncology publications to streamline communications and workstream development
- Support direct reports in the development and execution of plans to support Verastem's presence at global oncology congresses.
- Execute work in a timely manner according to plan prioritization, available resources and following internal policies, good publication practices and highest standards quality.
- Track and report the progress of Medical Communications activities across both assets, and communicate these to senior management
- Maintain current knowledge of the scientific publication planning…
(If this job is in fact in your jurisdiction, then you may be using a Proxy or VPN to access this site, and to progress further, you should change your connectivity to another mobile device or PC).